RainDance Technologies, CLC bio Collaborate To Develop Specialised Software

RainDance Technologies and CLC bio have announced a partnership to develop specialised software for the analysis of targeted resequencing data generated by workflows incorporating RainDance’s Sequence Enrichment Solution and DNA sequencing platforms.

As a first step, CLC bio will release an expansion to its CLC Genomics Workbench, enabling scientists to analyse data faster and more effectively when using the RainDance solution for large scale targeted resequencing studies. The software is already in use by RainDance scientists and will be released for commercial sale later this month.

The CLC bio/RainDance solution can be used with any next-generation sequencing workflow, giving customers the freedom to choose between the Illumina Genome Analyser, Roche/454, or ABI SOLiD system.

Christopher McNary, president and chief executive officer of RainDance Technologies, said: “The rapid and efficient analysis of genomic data plays an important role in searching for the variants in large populations that cause cancer and other devastating diseases.

“By partnering with CLC bio, we can provide researchers with a solution that leverages the power of our innovative microdroplet-based technology to provide the highest quality results in a simple, yet powerful workflow. This capability will help accelerate the advent of personalised medicine and make profound contributions to health and human disease research.”